These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 39094510

  • 1. Discovery of novel amide derivatives against VEGFR-2/tubulin with potent antitumor and antiangiogenic activity.
    Liu Z, Mao S, Li H, Liu W, Tao J, Lu Y, Dong H, Zhang J, Song C, Duan Y, Yao Y.
    Bioorg Chem; 2024 Oct; 151():107679. PubMed ID: 39094510
    [Abstract] [Full Text] [Related]

  • 2. Discovery of novel tubulin/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency.
    Wang Y, Sun M, Wang Y, Qin J, Zhang Y, Pang Y, Yao Y, Yang H, Duan Y.
    Eur J Med Chem; 2021 Dec 05; 225():113790. PubMed ID: 34454126
    [Abstract] [Full Text] [Related]

  • 3. Discovery of novel thiophene-3-carboxamide derivatives as potential VEGFR-2 inhibitors with anti-angiogenic properties.
    Li T, Wang J, Feng L, Zhou Q, Xie Q, Shen Y, Ji R, Liu X, Wang Y, Hu C.
    Bioorg Chem; 2024 Jun 05; 147():107358. PubMed ID: 38626490
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis, and biological evaluation of naphthalene imidazo[1,2-b]pyridazine hybrid derivatives as VEGFR selective inhibitors.
    Wang S, Gan L, Han L, Deng P, Li Y, He D, Chi H, Zhu L, Li Y, Long R, Gan Z.
    Arch Pharm (Weinheim); 2024 Oct 05; 357(10):e2400411. PubMed ID: 39008876
    [Abstract] [Full Text] [Related]

  • 5. Discovery of novel VEGFR-2 inhibitors embedding 6,7-dimethoxyquinazoline and diarylamide fragments.
    Wang R, Liu H, You YY, Wang XY, Lv BB, Cao LQ, Xue JY, Xu YG, Shi L.
    Bioorg Med Chem Lett; 2021 Mar 15; 36():127788. PubMed ID: 33460739
    [Abstract] [Full Text] [Related]

  • 6. Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect.
    Sana S, Reddy VG, Bhandari S, Reddy TS, Tokala R, Sakla AP, Bhargava SK, Shankaraiah N.
    Eur J Med Chem; 2020 Aug 15; 200():112457. PubMed ID: 32422489
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase.
    Yuan X, Yang Q, Liu T, Li K, Liu Y, Zhu C, Zhang Z, Li L, Zhang C, Xie M, Lin J, Zhang J, Jin Y.
    Eur J Med Chem; 2019 Oct 01; 179():147-165. PubMed ID: 31252306
    [Abstract] [Full Text] [Related]

  • 8. Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors.
    Yao Y, Huang T, Wang Y, Wang L, Feng S, Cheng W, Yang L, Duan Y.
    J Enzyme Inhib Med Chem; 2022 Dec 01; 37(1):652-665. PubMed ID: 35109719
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis, biological evaluation of benzoyl amide derivatives containing nitrogen heterocyclic ring as potential VEGFR-2 inhibitors.
    Shen FQ, Shi L, Wang ZF, Wang CR, Chen JJ, Liu Y, Qiu HY, Zhu HL.
    Bioorg Med Chem; 2019 Sep 01; 27(17):3813-3824. PubMed ID: 31327679
    [Abstract] [Full Text] [Related]

  • 10. Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect.
    Ibrahim TS, Hawwas MM, Malebari AM, Taher ES, Omar AM, Neamatallah T, Abdel-Samii ZK, Safo MK, Elshaier YAMM.
    J Enzyme Inhib Med Chem; 2021 Dec 01; 36(1):802-818. PubMed ID: 33730937
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities.
    Sun YX, Song J, Kong LJ, Sha BB, Tian XY, Liu XJ, Hu T, Chen P, Zhang SY.
    Eur J Med Chem; 2022 Feb 05; 229():114069. PubMed ID: 34971875
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and cytotoxic evaluation of new thieno[2,3-d]pyrimidine analogues as VEGFR-2/AKT dual inhibitors, apoptosis and autophagy inducers.
    Abd El-Mawgoud HK, AboulMagd AM, Nemr MTM, Hemdan MM, Hassaballah AI, Farag PS.
    Bioorg Chem; 2024 Sep 05; 150():107622. PubMed ID: 38996545
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and biological evaluation of new 2-methoxyestradiol derivatives: Potent inhibitors of angiogenesis and tubulin polymerization.
    Sun M, Zhang Y, Qin J, Ba M, Yao Y, Duan Y, Liu H, Yu D.
    Bioorg Chem; 2021 Aug 05; 113():104988. PubMed ID: 34034135
    [Abstract] [Full Text] [Related]

  • 14. New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis.
    Alsaif NA, Dahab MA, Alanazi MM, Obaidullah AJ, Al-Mehizia AA, Alanazi MM, Aldawas S, Mahdy HA, Elkady H.
    Bioorg Chem; 2021 May 05; 110():104807. PubMed ID: 33721808
    [Abstract] [Full Text] [Related]

  • 15. Biphenylurea/thiourea derivatives tagged with heteroarylsulfonamide motifs as novel VEGFR2 inhibitors; Design, synthesis and anti-angiogenic activity.
    Al-Ansary GH, Nasr T, Taha H, Fayad W, Mahgoub S.
    Bioorg Chem; 2021 Feb 05; 107():104640. PubMed ID: 33485105
    [Abstract] [Full Text] [Related]

  • 16. A new diaryl urea compound, D181, induces cell cycle arrest in the G1 and M phases by targeting receptor tyrosine kinases and the microtubule skeleton.
    Zhang J, Zhou J, Ren X, Diao Y, Li H, Jiang H, Ding K, Pei D.
    Invest New Drugs; 2012 Apr 05; 30(2):490-507. PubMed ID: 21080210
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA, Abdel-Mohsen HT, El Kerdawy AM, Ragab FAF, Ali MM, Abu-Bakr SM, Girgis AS, El Diwani HI.
    Eur J Med Chem; 2017 Aug 18; 136():315-329. PubMed ID: 28505536
    [Abstract] [Full Text] [Related]

  • 18. Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents.
    El-Metwally SA, Abou-El-Regal MM, Eissa IH, Mehany ABM, Mahdy HA, Elkady H, Elwan A, Elkaeed EB.
    Bioorg Chem; 2021 Jul 18; 112():104947. PubMed ID: 33964580
    [Abstract] [Full Text] [Related]

  • 19. Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors.
    Sun M, Yuan M, Kang Y, Qin J, Zhang Y, Duan Y, Wang L, Yao Y.
    J Enzyme Inhib Med Chem; 2022 Dec 18; 37(1):339-354. PubMed ID: 34979843
    [Abstract] [Full Text] [Related]

  • 20. A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling.
    Lien JC, Chung CL, Huang TF, Chang TC, Chen KC, Gao GY, Hsu MJ, Huang SW.
    Br J Pharmacol; 2019 Oct 18; 176(20):4034-4049. PubMed ID: 31368127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.